One of the most promising biological markers in the pathogenesis of CRC is the proto-oncogenes c-MET (mesenchymal–epithelial transition factor gene) which encodes the tyrosine kinase receptor for hepatocyte growth factor/scatter factor (HGF/SF). The gene discussed is MET; the disease is colorectal carcinoma.